Inhalational anthrax

Respiratory Care Clinics of North America

Volumn 10, Issue 1, 2004, Pages 75-82

  Cuneo, Brian M ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; AMOXICILLIN; AMPICILLIN; ANTHRAX VACCINE; ANTIBIOTIC AGENT; BETA LACTAMASE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DEXAMETHASONE; DOXYCYCLINE; DROTRECOGIN; FLUDROCORTISONE; HYDROCORTISONE; HYPERTENSIVE FACTOR; IMIPENEM; PENICILLIN G; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RECOMBINANT PROTEIN; RIFAMPICIN; STEROID; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTHRAX; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE; BRAIN HEMORRHAGE; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DISEASE TRANSMISSION; DISPERSION; DRUG DOSE REGIMEN; DRUG EFFICACY; EARLY DIAGNOSIS; HEALTH CARE PERSONNEL; HUMAN; IMMUNIZATION; INFECTION CONTROL; INFLUENZA; INHALATION; LABORATORY TEST; MEDICAL CARE; NONHUMAN; PHYSICAL EXAMINATION; RADIODIAGNOSIS; SKIN MANIFESTATION; SYMPTOMATOLOGY; TERATOGENICITY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 1342283214     PISSN: 10785337     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5337(03)00050-9     Document Type: Review

References (19)

1. Bartlett J.G. Inglesby T.V. Borio L. Management of anthrax Clin Infect Dis 35 7 2002 851-858
2. Morens D.M. Epidemic anthrax in the eighteenth century, the Americas Emerg Infect Dis 8 10 2002 1160-1162
3. Inglesby T.V. O'Toole T.O. Henderson D.A. et al. Anthrax as a biological weapon, 2002: updated recommendations for management JAMA 288 17 2002 2236-2252
4. Mierzejewski J. Bartoszcze M. Decontamination of soil after bacterial warfare experiments on Gruinard Island Prezegl Epidemiol 45 3 1991 197-205
5. Schwartz M.N. Recognition and management of anthrax-an update N Engl J Med 345 22 2003 1621-1626
6. Begley S. Tracking anthrax: the history of weaponized anthrax suggests that investigators have no shortage of suspects in the bioattacks. Newsweek, Oct. 29, 2003. p. 36-39.
7. Use of anthrax vaccine in the United States-recommendations of the Advisory Committee on Immunization Practices Advisory Committee on Immunization Practices, Recommendations and Reports 49 RR15 2000 1-20
8. Jerrigan J.A. Stephens D.S. Ashford D.A. et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States Emerg Infect Dis 7 6 2001 933-944
9. Considerations for distinguishing influenza-like illness from inhalational anthrax MMWR 50 44 2001 984-986
10. Krol C.M. Uszynski M. Dillon E.H. et al. Dynamic CT features of inhalational anthrax infection Am J Roentgenol 178 2002 1063-1066
11. Ashford D. Bell D. Blank S. et al. Conference summary: clinical issues in the prophylaxis, diagnosis, and treatment of anthrax Emerg Infect Dis 8 2 2002 222-225
12. Hoffmaster A.R. Meyer R.F. Bowen M.P. et al. Letters: evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis Emerg Infec Dis 8 10 2002 1178-1182
13. Gans J.D. Van De Beek D. Dexamethasone in adults with bacterial meningitis N Engl J Med 347 20 2002 1549-1556
14. Annane D. Sebille V. Charpentier C. et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 288 2002 862-871
15. Cooper M.S. Stewart P.M. Corticosteroid insufficiency in acutely ill patients N Engl J Med 348 2003 727-734
16. Bernard G.R. Vincent J.L. Laterre P.F. et al. Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 10 2001 699-709
17. Notice to readers: use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices MMWR 51 45 2002 1024-1026
18. Shepard C.W. Soriano-Gabarro M. Zell E.R. et al. Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence Emerging Infectious Diseases 8 10 2002 1124-1132
19. Infectious Disease Society of America. Anthrax medical summary. Available at: www.idsociety.org . Accessed February 25, 2003.